Study S001910
Investigating Enteroendocrine Dysfunction, Metabolism, and Response to Liraglutide in Patients With Maturity-onset Diabetes of the Young (MODY)
Registration
Registered primary outcomes
- Blood sugar control - HbA1C [Baseline and 3 months after study treatment initiation]
- BMI [baseline, 1 month, 2 months, and final study visit 3 months after study treatment initiation]
Linked records (0)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
No records link to this registration yet.